"The START (a Streamlined ART Initiation Strategy) Study"

NACompletedINTERVENTIONAL
Enrollment

12,024

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
HIV
Interventions
BEHAVIORAL

START

"INTERVENTION: START is clinic-level (not individual-patient) intervention to catalyze the process of ART initiation among HIV-infected adults who meet CD4-based criteria for combination ART (e.g., adults with a CD4 T cell level \< 350/ul). The three START components are: (1) real-time point-of-care CD4 testing using the Alere PIMA platform to ascertain treatment eligibility in real time at first presentation to care, (2)targeted knowledge transfer(i.e., dissemination) of recent scientific evidence regarding effects rapid ART initiation on survival to front line health care workers; and 3)feedback and reporting to clinic and providers. There three components represent empirically validated steps in the PRECEED implementation model.~This intervention will be implemented at all Makerere Joint AIDS Program (MJAP) clinics in Kampala and Mbarara districts in a step-wedge design."

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT01810289 - "The START (a Streamlined ART Initiation Strategy) Study" | Biotech Hunter | Biotech Hunter